Home > Drug Search >
  • company_query: AlphaBeta Pharma
  •   > 
Drug Filter
Category:
chemistry (12) biology (23)
Status:
Approved (7) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (16) Phase Ⅰ (7)
Clinical Stage:
Pending (3) Active (17) Discontinued (8)
Bio-Type:
Cell therapy (1) Vaccine (15) Recombinant cytokines (5) Whole antibody (1) ADC (1)
Indication:
Alzheimer's disease (AD) (1) Anemia (1) Asthma (1) Atopic dermatitis (1) Breast cancer (3) Chronic obstructive pulmonary disease (COPD) (1) Avian influenza (2) Diabetic macular edema (1) Diarrhea (1) Follicular lymphoma (1) Gastric cancer (1) Retinal disorders (1) HBV infection (2) HCV infection (1) Influenza virus infection (2) Major depressive disorder (MDD) (1) Multiple sclerosis (MS) (2) Myeloid leukemia (1) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Overactive bladder (OAB) (1) Parkinson's disease (PD) (1) Viral infections (1) Prostate cancer (1) Schizophrenia (1) Solid tumours (2) Ulcerative colitis (1) Influenza A virus infections (2) Influenza B virus infection (2) Parvovirus infections (1) Helicobacter pylori infection (1) Age-related macular degeneration (AMD) (1) Pain (1) Acute Lung Injury (1) Neutropenia (1) Renal carcinoma (1) Acute ischemic stroke (AIS) (2) Glioblastoma (1) Allergic asthma (1) Diabetic retinopathy (1) Vasomotor symptoms (1) Bacterial infection (1) Hypersensitivity (1)
Aprv. Year:
2013 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top